In re Zyprexa Products Liability Litigation
| Court | U.S. District Court — Eastern District of New York |
| Writing for the Court | Weinstein |
| Citation | In re Zyprexa Products Liability Litigation, 489 F.Supp.2d 230 (E.D. N.Y. 2007) |
| Decision Date | 11 June 2007 |
| Docket Number | No. 04-MD-1596.,No. 06-CV-1729.,04-MD-1596.,06-CV-1729. |
| Parties | In re ZYPREXA PRODUCTS LIABILITY LITIGATION. Monty Souther, Robert Cusella, Judith New, Beverly Pearson, Donna Worthington, Plaintiffs, v. Eli Lilly & Company, Defendant. |
J. Christopher Ide, Michael J. Joseph Miller, Miller & Associates, Alexandria, NY, for Plaintiffs.
Lawrence J. Myers, Smith Moore, Atlanta, GA, Samuel J. Abate, Jr., Pepper Hamilton LLP, New York, NY, for Defendant.
MEMORANDUM, ORDER, & JUDGMENT
Get this document and AI-powered insights with a free trial of vLex and Vincent AI
Get Started for FreeStart Your Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant
-
Access comprehensive legal content with no limitations across vLex's unparalleled global legal database
-
Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength
-
Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities
-
Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting
Start Your Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant
-
Access comprehensive legal content with no limitations across vLex's unparalleled global legal database
-
Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength
-
Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities
-
Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting
Start Your Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant
-
Access comprehensive legal content with no limitations across vLex's unparalleled global legal database
-
Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength
-
Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities
-
Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting
Start Your Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant
-
Access comprehensive legal content with no limitations across vLex's unparalleled global legal database
-
Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength
-
Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities
-
Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting
Start Your Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant
-
Access comprehensive legal content with no limitations across vLex's unparalleled global legal database
-
Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength
-
Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities
-
Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting
Start Your Free Trial
149 cases
-
Horne v. Novartis Pharmaceuticals Corp.
... ... classifications and warnings approved and mandated by the FDA for products containing ACE inhibitors, such as Lotensin HCT®. [Memorandum in Support ... manufacturers to propose "defensive labeling" to avoid State liability, which, if implemented, could result in scientifically unsubstantiated ... See, e.g., In re Vioxx Products Liability Litigation, 501 F.Supp.2d 776, 788 (E.D.La.2007); In re Zyprexa Products Liab ... ...
-
Kellogg v. Wyeth
... ... Robins Company, Inc. and American Home Products Corporation; Schwarz Pharma, Inc.; Actavis, Inc.; Actavis-Elizabeth, ... eight counts in her second amended complaint, five are products liability claims brought against all defendants, in which she asserts breach of a ... At the times relevant to this litigation, 1 the FDA required prescription drug labeling to "contain a summary of ... See In re Zyprexa Prods. Liab. Litig., 489 F.Supp.2d 230, 276-77 (E.D.N.Y.2007) ("Jury ... ...
-
Knipe v. Smithkline Beecham
... ... No. 117) ... This litigation commenced on July 10, 2006, when Plaintiffs sued Defendant for the ... and taking appropriate action on the marketing of regulated products" and to "protect the public health by ensuring that ... drugs are safe ... disclosures of risk information can expose a manufacturer to liability under the act if the additional statement is unsubstantiated or otherwise ... See, e.g., In re Zyprexa Prods. Liab. Litig., 489 F.Supp.2d 230, 273-74 (E.D.N.Y.2007); Colacicco ... ...
-
Warner Bros. Records Inc. v. Lime Group Llc.
... ... the programs Napster, Kazaa, Morpheus, and Grokster, have faced liability for copyright infringement, on the ground that they facilitated ... Compl., Exs. A & B (as revised, Jan. 31, 2008).) In this litigation, Plaintiffs have provided documentation establishing that they own the ... applied by the expert to the facts of the case.’ ” In re Zyprexa Prods. Liab. Litig., 489 F.Supp.2d 230, 284 (E.D.N.Y.2007) (quoting ... liability is that a party who distributes infringement-enabling products or services may facilitate direct infringement on a massive scale, making ... ...
Get Started for Free
8 firm's commentaries
-
FDA Device Clearance – Clearly Relevant
...a manufacturer of liability.” Salmon v. Parke Davis & Co., 520 F.2d 1359, 1362 (4th Cir. 1975). Thus, in In re Zyprexa Products Liability Litigation, 489 F. Supp.2d 230 (E.D.N.Y. 2007), Judge Weinstein (who literally “wrote the book” about federal evidence) held that a jury “may be guided” ......
-
More Thoughts On Bartlett
...Cir. 2007); Phelps v. Sherwood Medical Industries, 836 F.2d 296, 302-303 (7th Cir. 1987); In re Zyprexa Products Liability Litigation v. Eli Lilly & Co., 489 F. Supp.2d 230, 267 (E.D.N.Y. 2007); Soufflas v. Zimmer, Inc., 474 F. Supp.2d 737, 751 (E.D. Pa. 2007); Chamian v. Sharplan Lasers, I......
-
Embedded Fraud On The FDA
...have to do the same for decisions from district courts in the Second Circuit, there aren’t any. While In re Zyprexa Products Liability Litigation, 489 F.Supp.2d 230, 273-75 (E.D.N.Y. 2007), cited Desiano a lot, that was for things like a presumption against preemption. Zyprexa wasn’t a frau......
-
More Thoughts On Bartlett
...Cir. 2007); Phelps v. Sherwood Medical Industries, 836 F.2d 296, 302-303 (7th Cir. 1987); In re Zyprexa Products Liability Litigation v. Eli Lilly & Co., 489 F. Supp.2d 230, 267 (E.D.N.Y. 2007); Soufflas v. Zimmer, Inc., 474 F. Supp.2d 737, 751 (E.D. Pa. 2007); Chamian v. Sharplan Lasers, I......
Get Started for Free
9 books & journal articles
-
Marketing pharmaceutical products in the twenty-first century: an analysis of the continued viability of traditional principles of law in the age of direct-to-consumer advertising.
...an individualized medical judgment bottomed on a knowledge of both patient and palliative."); see also Ill re Zyprexa Prods. Liab. Litig., 489 F. Supp. 2d 230, 266 (E.D.N.Y. 2007) (stating that "'[w]hether the physician in fact reads [the drug manufacturer's] warning or passes its contents ......
-
Physician Conflicts of Interest in Court: Beyond the Independent Physician Litigation Heuristic
...or an Anachronism?, 10 KAN. J.L. & PUB. POL'Y 98, 99 (2000). 145. Souther v. Eli Lilly & Co. (In re Zyprexa Prods. Liab. Litig.), 489 F. Supp. 2d 230, 244 (E.D.N.Y. 2007).146. Hall, supra note 7, at 207.147. Id. at 207-08.148. Reyes v. Wyeth Labs., 498 F.2d 1264, 1277 (5th Cir. 1974).149. 4......
-
Product Liability - Frank P. Brannen Jr. and Jacob E. Daly
...thus, state-law failure-to-warn claims against drug manufacturers are not expressly preempted."); In re Zyprexa Prods. Liab. Litig., 489 F. Supp. 2d 230, 276 (E.D.N.Y. 2007) ("Congress has not spoken on the issue of preemption as related to prescription drugs, and this silence is telling.")......
-
CHAPTER § 9.05 Preemption
...Kelly v. Wyeth, No. 20033314F, 2007 WL 1302589 (Mass. Super. Ct. Apr. 12, 2007). Second Circuit: In re Zyprexa Prod. Liab. Litig., 489 F. Supp.2d 230 (E.D.N.Y. June 2007). Third Circuit: Knipe v. SmithKline Beecham Corp., 583 F. Supp.2d 553 (E.D. Pa. 2008); Perry v. Novartis Pharm. Corp., 4......
Get Started for Free